Add BrightSurf on Google Email

A promising vaccine approach to induce longer-lasting protective immunity against COVID-19: NUS Medicine-Monash University study

A team of scientists has developed a novel vaccine approach that induces long-lasting protective immunity against SARS-CoV-2 virus in pre-clinical models. The Clec9A-RBD antibody construct targets specific dendritic cells, leading to exceptional durability of immune responses and potential to address shortcoming of current mRNA vaccines.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalMolecular Therapy·TypeRandomized controlled/clinical trial·DateMay 6, 2024

Singapore study identifies immunity threshold for protection against COVID-19 in children

Researchers found that T cells and memory B cells provide durable protection against symptomatic SARS-CoV-2 infection, with levels attainable after two doses of mRNA vaccination. The study suggests a two-dose vaccination regimen for children against COVID-19.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateMay 2, 2024

Moffitt researchers discover new therapeutic target for non-small cell lung cancer

Researchers at H. Lee Moffitt Cancer Center & Research Institute discovered a new therapeutic target for non-small cell lung cancer by targeting the Jagged2 protein. Disrupting this signaling pathway activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalImmunity·TypeExperimental study·DateApr 18, 2024

Insilico Medicine develops novel PTPN2/N1 inhibitor for cancer immunotherapy using generative AI

Researchers at Insilico Medicine have developed a novel PTPN2/N1 inhibitor with improved oral absorption and robust antitumor efficacy using the company's generative AI engine. The new compound demonstrates enhanced biological activities compared to existing inhibitors, offering new treatment possibilities for cancer patients.

SourceInSilico Medicine·JournalEuropean Journal of Medicinal Chemistry·DateApr 11, 2024

Swedish study indicates a significant decline of neutralising antibodies to monkeypox virus already during the first month after vaccination

A Swedish study reveals that neutralising antibodies to the monkeypox virus decline significantly after two doses of the MVA-BN vaccine within the first month. The findings suggest that a booster dose may be necessary to maintain immunity, emphasizing the need for scientific evidence before policy decisions are made.

Plant receptors that control immunity and development share a common origin

Researchers have discovered that plant immune receptors and growth-related proteins share a common evolutionary ancestry, allowing for the creation of hybrid receptors with enhanced functionality. This breakthrough could lead to the development of disease-resistant crops by isolating and engineering immune receptors from various plants.

SourceRIKEN·JournalNature Communications·TypeExperimental study·DateFeb 1, 2024

New vaccine design uses immunity against influenza to offer faster protection against emerging pathogens

A new vaccine design has been developed by a UC Riverside-led research team, which uses preexisting immunity to the influenza virus to help kickstart the production of antibodies against SARS-CoV-2. The vaccine aims to speed up the immune response and provide better protection for people who still lack immunity to the coronavirus.

SourceUniversity of California - Riverside·JournalJournal of Virology·TypeExperimental study·DateJan 17, 2024

B cell deficient patients gain protective T cell immunity following SARS-CoV-2 vaccination and infection, study finds

Researchers found that vaccinated B cell-deficient individuals have a robust T cell response to SARS-CoV-2, despite lack of anti-spike antibodies, resulting in markedly reduced rates of hospitalization and severe COVID-19. This study provides reassuring evidence for immunocompromised patients to get vaccinated.

SourceRagon Institute of MGH, MIT and Harvard·JournalScience Translational Medicine·TypeObservational study·DateDec 18, 2023

New research shows maternal dengue immunity worsens birth defects caused by Zika virus

A recent study led by Duke-NUS Medical School found that prior maternal dengue immunity substantially increases the risk of severe birth defects induced by Zika virus infection during pregnancy. Pregnant mothers with pre-existing dengue antibodies are more likely to experience microcephaly and brain damage in their foetuses after Zika ...

SourceDuke-NUS Medical School·JournalScience Translational Medicine·TypeExperimental study·DateNov 10, 2023

Gender-neutral HPV vaccination best at preventing cervical cancer

A study published in Cell Host and Microbe found that gender-neutral HPV vaccination is effective in preventing cervical cancer by inducing a stronger herd immunity. The vaccine protects against high-risk HPV types 16 and 18, which cause 70% of all HPV-related cervical cancers, and also provides cross-protection against low-risk types.

SourceKarolinska Institutet·JournalCell Host & Microbe·TypeObservational study·DateNov 8, 2023

Colostrum key to saving beef calves from trouble

A recent study found that insufficient antibody transfer to newborn beef calves leads to negative health effects, including increased medical treatment needs and mortality rates. Researchers recommend beef calf-specific colostrum intervention strategies and better vaccine management for pregnant cows and heifers.

SourceNorth Carolina State University·JournalPreventive Veterinary Medicine·TypeObservational study·DateNov 7, 2023

Clinical trial finds live vaccinations safe for liver, kidney transplant recipients

A new study published in JAMA Network Open found live vaccinations safe and effective for children who have received liver or kidney transplants, offering protection against life-threatening conditions. The study showed high antibody levels and minimal adverse events following vaccination.

SourceCincinnati Children's Hospital Medical Center·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateOct 16, 2023

Immune system ageing can be revealed by CT scan

A new study from Linköping University has found that the appearance of the thymus gland in chest CT scans is linked to immune system ageing. The researchers examined over 1,000 Swedish individuals aged 50-64 and found that fatty degeneration of the thymus was more common in men and those with abdominal obesity. Lifestyle factors such a...

SourceLinköping University·JournalImmunity & Ageing·TypeObservational study·DateOct 13, 2023

Antigen testing can reduce, but not eliminate, the risk of COVID-19 clusters according to mathematical model

Researchers found that antigen testing significantly reduces the probability of cluster occurrence by identifying and isolating infected persons. However, it may not be effective against highly infectious mutant strains like Omicron, highlighting the need for booster vaccination campaigns and other infection control measures.

SourceNagoya University·JournalProceedings of the National Academy of Sciences·DateOct 3, 2023

Trivalent vaccine candidate fights measles, mumps, SARS-CoV-2

Scientists have developed a trivalent vaccine candidate that provides broad and long-lasting protection against COVID-19 infection by delivering the vaccine via the nose. The vaccine triggers a strong neutralizing antibody response and protects mucosal areas, preventing disease symptoms.

SourceOhio State University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateOct 2, 2023

Immune cell map reveals origin of subcellular response to microbes, researchers report

Researchers have created an 'immune cell map' that reveals the origin of neutrophils' subcellular response to microbes. The study found that a specific type of glycoprotein is responsible for the restricted subcellular origin, and this discovery may lead to refined personalized immune responses.

SourceInstitute for Glyco-core Research (iGCORE), Tokai National Higher Education and Research System·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateOct 1, 2023

Study finds immune cells in older adults resemble those in newborns and children, but fall short in virus detection

Research finds that immune cells in older adults are similar to those in newborns and children, but less effective at recognizing infected cells. The study, published in Nature Immunology, suggests that tailored vaccines and therapies could be developed for different age groups based on the unique characteristics of killer T cells.

SourceThe Peter Doherty Institute for Infection and Immunity·JournalNature Immunology·TypeExperimental study·DateSep 25, 2023

Flu: Interferon-gamma from T follicular helper cells is required to create lung-resident memory B cells

Scientists have found that lung-resident memory B cells, critical for pulmonary immunity, require interferon-gamma produced by T follicular helper cells to differentiate. These long-lived immune cells migrate to the lungs from draining lymph nodes and lie in wait to react quickly to future infections.

SourceUniversity of Alabama at Birmingham·JournalImmunity·TypeExperimental study·DateSep 13, 2023

Immunity to COVID-19 reduces contagiousness

A study of 50,000 COVID-19 cases found that immunity following infection provides better protection against transmission than vaccination, but only for a short period. Vaccination reduces contagiousness over a longer time, making it essential to consider simple public health measures like air filtration and mask-wearing.

SourceUniversité de Genève·JournalNature Communications·TypeNews article·DateSep 12, 2023

Rural environment supports children’s immune systems

A new study has found that children raised in rural areas with plenty of outdoor time and animal exposure develop better-regulated immune systems than urban counterparts. Early life immune development is highly dependent on living environment and lifestyle factors, and researchers say this can have long-term consequences for disease risk.

SourceUniversity College Cork·JournalAllergy·TypeRandomized controlled/clinical trial·DateAug 3, 2023

Three doses of COVID-19 vaccine leads to catch-up antibody responses among the particularly vulnerable

A study from the University of Gothenburg found that even vulnerable people with compromised immune systems achieved good antibody levels after three doses of COVID-19 mRNA vaccine. This is particularly significant for those at risk of severe Covid-19, as they showed catch-up antibody responses and high levels of hybrid immunity.

SourceUniversity of Gothenburg·JournalInfectious Diseases·TypeObservational study·DateAug 1, 2023

Scientific breakthrough harnesses mRNA technology to develop powerful malaria vaccine

A breakthrough mRNA vaccine has been developed to target and stimulate protective immune cell responses against malaria. The vaccine combines an RNA-based approach with a liver-specific adjuvant, generating resident memory cells that halt malaria infection in the liver, providing a broader and more protective immune response.

SourceThe Peter Doherty Institute for Infection and Immunity·JournalNature Immunology·TypeExperimental study·DateJul 20, 2023

All the immunity, none of the symptoms

Researchers found that an iron-rich diet can prevent deadly symptoms in mice during active infection, while a functional adaptive immune system is required for immunity against future infections. The study paves the way for the development of new vaccines that could promote immunity for those with diarrheal diseases.

SourceSalk Institute·JournalScience Advances·TypeExperimental study·DateJun 23, 2023